NATIXIS ADVISORS, L.P. - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 211 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 3.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
NATIXIS ADVISORS, L.P. ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$984
-3.8%
35,678
+4.8%
0.00%0.0%
Q2 2023$1,023
-23.1%
34,031
-7.4%
0.00%
-40.0%
Q1 2023$1,331
+5.0%
36,744
+3.4%
0.01%0.0%
Q4 2022$1,268
-99.9%
35,550
+2.2%
0.01%0.0%
Q3 2022$1,178,000
+22.3%
34,795
+4.5%
0.01%
+25.0%
Q2 2022$963,000
-4.3%
33,298
+7.0%
0.00%0.0%
Q1 2022$1,006,000
+27.8%
31,126
+15.3%
0.00%
+33.3%
Q4 2021$787,000
+33.8%
26,997
+22.5%
0.00%
+50.0%
Q3 2021$588,000
-2.6%
22,044
+12.3%
0.00%
-33.3%
Q2 2021$604,000
+43.5%
19,625
+21.9%
0.00%
+50.0%
Q1 2021$421,000
+3.4%
16,100
-0.6%
0.00%0.0%
Q4 2020$407,000
+57.1%
16,196
+30.4%
0.00%0.0%
Q3 2020$259,000
-22.5%
12,422
-11.6%
0.00%0.0%
Q2 2020$334,000
-73.0%
14,045
-73.1%
0.00%
-77.8%
Q4 2019$1,237,000
-30.7%
52,152
-19.7%
0.01%
-35.7%
Q3 2019$1,785,000
-32.5%
64,945
-18.7%
0.01%
-36.4%
Q2 2019$2,643,000
+314.9%
79,877
+210.3%
0.02%
+175.0%
Q3 2016$637,000
+31.9%
25,746
+8.6%
0.01%
+14.3%
Q2 2016$483,00023,7010.01%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
HealthInvest Partners AB 335,000$8,934,00013.38%
ASHFORD CAPITAL MANAGEMENT INC 1,016,665$27,114,0002.46%
Bruce & Co., Inc. 402,105$10,724,0002.28%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 297,500$7,934,0001.91%
ARMISTICE CAPITAL, LLC 3,900,000$104,013,0001.76%
Bridge City Capital, LLC 108,884$2,904,0001.32%
S&T BANK/PA 316,098$8,430,0001.31%
Kent Lake Capital LLC 100,000$2,667,0001.15%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 331,140$8,832,0001.02%
Prairiewood Capital, LLC 45,297$1,208,0000.99%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders